Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design.
about
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease.The use of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and hypertension: a focus on African-American populations.Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.Progress in the Presence of Failure: Updates in Chronic Systolic Heart Failure Management.Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial.Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus.Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line : Editorial to: "Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes" by N. Hammoudi et al.Un-sweetening the Heart: Possible pleiotropic effects of SGLT2 inhibitors on cardio and cerebrovascular alterations in resistant hypertensive subjects.The Effect of Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibitors on Cardiometabolic Profile; Beyond the Hypoglycaemic Action.
P2860
Q33882438-13C4DBAC-AF03-4145-B4A4-155502B8D3C4Q38679997-7203ABEE-298E-4D1C-849F-E96B1ECEB304Q38870752-FAA3EE3E-2FDF-4031-B836-402B6CE69133Q39013664-7C0979A0-996E-499F-8BCE-78FB4029D78DQ39245449-53316C6A-359E-4026-83CE-EC5800F5B04EQ39317320-6504A4AD-EB10-45AD-971E-67FD1CAAB097Q42376648-4759992A-38C5-4E91-B1B0-D7274A69E166Q47137994-E0EF6983-D89C-4545-B63C-2E1C3A6563E4Q48363461-D64D7A99-D0BD-4807-B0AA-9C0A5691D8D3Q49550551-489D3AAB-0B48-494F-AF3D-4A03C61E7DEAQ51034590-BDC50AB9-D35E-4844-85EC-1A8E9F55CA33
P2860
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Research into the effect Of SG ...... M) trial rationale and design.
@en
Research into the effect Of SG ...... failure and diabetes mellitus
@nl
type
label
Research into the effect Of SG ...... M) trial rationale and design.
@en
Research into the effect Of SG ...... failure and diabetes mellitus
@nl
prefLabel
Research into the effect Of SG ...... M) trial rationale and design.
@en
Research into the effect Of SG ...... failure and diabetes mellitus
@nl
P2093
P2860
P50
P1476
Research into the effect Of SG ...... RM) trial rationale and design
@en
P2093
Allan D Struthers
Amir Fathi
Jagdeep S S Singh
Keeran Vickneson
P2860
P2888
P356
10.1186/S12933-016-0419-0
P407
P577
2016-07-15T00:00:00Z
P6179
1007581365